This is a StreetInsider.com Premium Only Page

Flex Pharma (FLKS) – Press Releases

Jul 18, 2019 05:05 PM Flex Pharma Announces Rights Dividend

Jul 12, 2019 04:05 PM Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting

Jun 25, 2019 07:00 AM Flex Pharma Announces Broker Authority to Vote on Certain Proposals

Jun 17, 2019 07:00 AM Flex Pharma Announces Overwhelming Support to Date for the Proposed Merger with Salarius Pharmaceuticals but More Votes are Needed to Complete the Merger

Jun 10, 2019 07:00 AM Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals

May 1, 2019 07:00 AM Flex Pharma Reports First Quarter 2019 Financial Results

Mar 6, 2019 07:00 AM Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Jan 4, 2019 07:00 AM Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer

Dec 6, 2018 03:30 AM Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer

Nov 5, 2018 07:00 AM Flex Pharma Reports Third Quarter 2018 Financial Results

Aug 15, 2018 05:17 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Flex Pharma, Newell, and PolarityTE and Encourages Investors to Contact the Firm

Aug 1, 2018 07:00 AM Flex Pharma Reports Second Quarter 2018 Financial Results

Jul 12, 2018 08:32 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MabVax Therapuetics Holdings, Flex Pharma, Inc. and Ormat Technologies, Inc. and Encourages Investors t

Jun 22, 2018 08:05 PM Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Flex Pharma, Inc. (FLKS) and Encourages Investors to Contact the Firm

Jun 13, 2018 07:00 AM Flex Pharma Announces Corporate Update

May 2, 2018 07:00 AM Flex Pharma Reports First Quarter 2018 Financial Results

Apr 25, 2018 03:19 PM Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018

Mar 26, 2018 07:00 AM Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis

Mar 7, 2018 07:00 AM Flex Pharma Reports Year End 2017 Financial Results

Feb 28, 2018 04:00 PM Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018

Feb 8, 2018 06:13 AM New Study Shows HOTSHOT™ Provides Relief From Muscle Soreness For Athletes Of All Types

Feb 6, 2018 12:00 PM Flex Pharma Presenting at BIO CEO on February 13, 2018

Nov 28, 2017 08:00 AM Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS

Nov 27, 2017 12:00 PM Arnold & Havas Media, Gear Communications Awarded HOTSHOT® Creative, Media & PR Duties

Nov 6, 2017 08:00 AM Flex Pharma Reports Third Quarter 2017 Financial Results

Nov 6, 2017 07:00 AM Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS

Nov 2, 2017 08:30 AM Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017

Oct 31, 2017 08:30 AM Flex Pharma Names Dr. Roger Tung to Its Board of Directors

Oct 16, 2017 08:30 AM Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US

Sep 6, 2017 04:40 PM Flex Pharma Presenting at Upcoming Investor Conferences in September 2017

Aug 2, 2017 07:30 AM Flex Pharma Reports Second Quarter 2017 Financial Results

Aug 1, 2017 07:30 AM Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US

Jul 31, 2017 07:30 AM Flex Pharma Names William McVicar President and Chief Executive Officer

Jul 26, 2017 08:00 AM Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017

Jul 25, 2017 07:30 AM FDA Grants Fast Track Designation to Flex Pharma’s FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS

Jun 5, 2017 04:10 PM Flex Pharma Announces Executive Leadership Transition

Jun 2, 2017 08:00 AM Flex Pharma’s Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium

May 30, 2017 09:23 AM Flex Pharma Presenting at Upcoming Investor Conferences in June 2017

May 3, 2017 07:15 AM Flex Pharma Reports First Quarter 2017 Financial Results

Apr 26, 2017 08:00 AM FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND

Apr 19, 2017 08:00 AM Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting

Apr 5, 2017 08:00 AM Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development

Mar 23, 2017 07:45 AM Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps

Mar 8, 2017 07:00 AM Flex Pharma Reports Year End 2016 Financial Results

Mar 1, 2017 03:36 PM Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017

Feb 15, 2017 02:52 PM Champion Triathlete Finds Solution For Struggle With Muscle Cramps

Feb 7, 2017 01:31 PM Flex Pharma to Present at the BIO CEO & Investor Conference

Jan 24, 2017 07:30 AM Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases

Dec 20, 2016 12:53 PM Champion Pro Football Fullback Goes On The Offense Against Game-Changing Cramps

Nov 21, 2016 06:07 PM Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference